Home/ Stocks/ STRO

Sutro Biopharma, Inc.

STRO XNAS

$23.57 +3.58 (+16.78%) ▲ 15-min delayed

Open

$23.21

High

$24.49

Low

$21.09

Volume

287.0K

Market Cap

$349.55M

About Sutro Biopharma, Inc.

Sutro Biopharma Inc is a clinical-stage drug discovery, development, and manufacturing company. It is mainly engaged in the development of biopharmaceutical products. The company manufactures next-generation protein therapeutics for cancer and autoimmune disorders through its proprietary integrated cell-free protein synthesis platform, XpressCF. Products offered by the company include STRO-001 for patients with multiple myeloma and non-Hodgkin lymphoma and STRO-002 for the treatment of ovarian and endometrial cancers. The company also pipeline contains STRO-004, STRO-006, STRO-00X, STRO-00Y, STRO-003, VAX24, VAX31, and Others.

Sector: BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES) Employees: 131 Website →

Key Financials

Period	Revenue	Net Income	EPS
Q3 2025	$9.69M	$-56,857,000	$-0.67
Q2 2025	$63.74M	$-11,499,000	$-0.14
Q1 2025	$17.40M	$-75,968,000	$-0.91
FY 2024	$62.04M	$-227,461,000	$-2.96

Related Market News

No specific coverage for STRO yet. Check out our latest market news or earnings calendar.

Get STRO Alerts

Stay ahead with breaking news, price alerts, and expert analysis on Sutro Biopharma, Inc..

Disclaimer: This page is for informational purposes only. Stock data is delayed by at least 15 minutes. Always conduct your own research and consult with a qualified financial advisor before making investment decisions.